Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcon stock logo
ALC
Alcon
$76.55
+1.6%
$80.60
$73.21
$99.20
$37.76B0.991.74 million shs1.79 million shs
Align Technology, Inc. stock logo
ALGN
Align Technology
$133.09
+2.0%
$137.18
$122.00
$246.19
$9.65B1.71.23 million shs1.05 million shs
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$70.26
+1.8%
$69.54
$61.78
$109.37
$13.97B1.022.34 million shs1.77 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$267.91
+0.7%
$251.07
$187.43
$352.33
$19.27B1.07806,518 shs583,075 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcon stock logo
ALC
Alcon
-1.85%+1.23%-5.85%-13.36%-20.97%
Align Technology, Inc. stock logo
ALGN
Align Technology
-0.78%+4.19%-6.22%-34.92%-44.45%
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
-1.55%+0.72%+1.37%-7.91%-34.57%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-0.69%+1.35%+6.33%+17.76%-8.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcon stock logo
ALC
Alcon
$76.55
+1.6%
$80.60
$73.21
$99.20
$37.76B0.991.74 million shs1.79 million shs
Align Technology, Inc. stock logo
ALGN
Align Technology
$133.09
+2.0%
$137.18
$122.00
$246.19
$9.65B1.71.23 million shs1.05 million shs
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$70.26
+1.8%
$69.54
$61.78
$109.37
$13.97B1.022.34 million shs1.77 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$267.91
+0.7%
$251.07
$187.43
$352.33
$19.27B1.07806,518 shs583,075 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcon stock logo
ALC
Alcon
-1.85%+1.23%-5.85%-13.36%-20.97%
Align Technology, Inc. stock logo
ALGN
Align Technology
-0.78%+4.19%-6.22%-34.92%-44.45%
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
-1.55%+0.72%+1.37%-7.91%-34.57%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-0.69%+1.35%+6.33%+17.76%-8.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alcon stock logo
ALC
Alcon
2.65
Moderate Buy$95.5024.76% Upside
Align Technology, Inc. stock logo
ALGN
Align Technology
2.47
Hold$210.0057.79% Upside
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
2.71
Moderate Buy$84.7520.62% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.85
Moderate Buy$321.8920.15% Upside

Current Analyst Ratings Breakdown

Latest COO, ALC, WST, and ALGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
Alcon stock logo
ALC
Alcon
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
10/8/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C-)Sell (D+)
10/8/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$170.00 ➝ $160.00
10/8/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
10/7/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$350.00
10/2/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$260.00 ➝ $275.00
10/1/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetSell$64.00
10/1/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageSell$64.00
9/30/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
9/29/2025
Alcon stock logo
ALC
Alcon
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$90.00 ➝ $85.00
9/27/2025
Alcon stock logo
ALC
Alcon
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
(Data available from 10/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alcon stock logo
ALC
Alcon
$9.91B3.81$5.54 per share13.82$43.70 per share1.75
Align Technology, Inc. stock logo
ALGN
Align Technology
$4.00B2.41$9.10 per share14.63$51.60 per share2.58
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$3.90B3.59$5.60 per share12.54$40.50 per share1.73
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.89B6.66$9.01 per share29.75$37.04 per share7.23
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alcon stock logo
ALC
Alcon
$1.02B$2.1535.6023.272.4210.70%6.92%4.89%11/11/2025 (Estimated)
Align Technology, Inc. stock logo
ALGN
Align Technology
$421.36M$5.9322.4414.871.4811.04%13.36%8.32%10/29/2025 (Confirmed)
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$392.30M$2.0334.6115.791.8410.08%9.82%6.54%12/4/2025 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$492.70M$6.6840.1134.094.7616.48%18.43%13.67%10/23/2025 (Estimated)

Latest COO, ALC, WST, and ALGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2025Q3 2025
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.38N/AN/AN/A$980.75 millionN/A
10/23/2025Q3 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.67N/AN/AN/A$788.42 millionN/A
8/27/2025Q3 2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$1.07$1.10+$0.03$0.49$1.06 billion$1.06 billion
8/19/2025Q2 2025
Alcon stock logo
ALC
Alcon
$0.71$0.76+$0.05$0.35$2.65 billion$2.62 billion
7/30/2025Q2 2025
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.57$2.49-$0.08$1.72$1.06 billion$1.01 billion
7/24/2025Q2 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.51$1.84+$0.33$1.82$725.11 million$766.50 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alcon stock logo
ALC
Alcon
N/AN/AN/AN/A4 Years
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
N/AN/AN/AN/AN/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.840.31%N/A12.57%N/A

Latest COO, ALC, WST, and ALGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/23/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.220.39%11/12/202511/12/202511/19/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alcon stock logo
ALC
Alcon
0.21
2.60
1.61
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.23
1.10
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
0.29
2.12
1.24
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.07
2.78
2.08

Institutional Ownership

CompanyInstitutional Ownership
Alcon stock logo
ALC
Alcon
53.86%
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
24.39%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Alcon stock logo
ALC
Alcon
N/A
Align Technology, Inc. stock logo
ALGN
Align Technology
0.66%
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
1.98%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.57%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alcon stock logo
ALC
Alcon
25,599493.24 millionN/AOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
20,94572.49 million72.01 millionOptionable
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
16,000198.81 million194.87 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60071.91 million71.50 millionOptionable

Recent News About These Companies

Analyzing CONMED (NYSE:CNMD) and West Pharmaceutical Services (NYSE:WST)
3 Reasons to Avoid WST and 1 Stock to Buy Instead

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alcon stock logo

Alcon NYSE:ALC

$76.55 +1.18 (+1.57%)
Closing price 03:59 PM Eastern
Extended Trading
$76.56 +0.01 (+0.01%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Align Technology stock logo

Align Technology NASDAQ:ALGN

$133.09 +2.62 (+2.01%)
Closing price 04:00 PM Eastern
Extended Trading
$132.93 -0.16 (-0.12%)
As of 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Cooper Companies stock logo

Cooper Companies NASDAQ:COO

$70.26 +1.24 (+1.80%)
Closing price 04:00 PM Eastern
Extended Trading
$70.12 -0.14 (-0.19%)
As of 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$267.91 +1.94 (+0.73%)
Closing price 03:59 PM Eastern
Extended Trading
$267.48 -0.44 (-0.16%)
As of 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.